A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cor Medix Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 160,734 shares of CRMD stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
160,734
Previous 238,659 32.65%
Holding current value
$1.29 Million
Previous $1.01 Million 31.32%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$4.08 - $6.39 $317,934 - $497,940
-77,925 Reduced 32.65%
160,734 $695,000
Q1 2024

May 13, 2024

BUY
$2.94 - $4.24 $8,699 - $12,546
2,959 Added 1.26%
238,659 $1.01 Million
Q4 2023

Feb 13, 2024

BUY
$3.0 - $4.01 $387,300 - $517,691
129,100 Added 121.11%
235,700 $886,000
Q3 2023

Nov 14, 2023

BUY
$3.6 - $4.46 $383,760 - $475,436
106,600 New
106,600 $394,000
Q1 2023

May 12, 2023

BUY
$3.22 - $4.61 $348,159 - $498,451
108,124 Added 146.91%
181,724 $752,000
Q4 2022

Feb 13, 2023

BUY
$2.81 - $4.45 $168,600 - $267,000
60,000 Added 441.18%
73,600 $311,000
Q3 2022

Nov 14, 2022

BUY
$2.82 - $7.52 $38,352 - $102,272
13,600 New
13,600 $38,000
Q2 2022

Aug 12, 2022

SELL
$2.73 - $5.61 $27,728 - $56,980
-10,157 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$3.83 - $6.24 $38,901 - $63,379
10,157 New
10,157 $56,000
Q4 2021

Feb 11, 2022

SELL
$4.47 - $5.56 $527,464 - $656,085
-118,001 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$4.46 - $7.11 $526,284 - $838,987
118,001 New
118,001 $549,000
Q1 2021

May 13, 2021

SELL
$6.84 - $17.58 $298,908 - $768,245
-43,700 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$5.0 - $9.15 $218,500 - $399,855
43,700 New
43,700 $325,000
Q2 2020

Aug 13, 2020

SELL
$3.08 - $6.56 $397,012 - $845,584
-128,900 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$2.35 - $7.08 $170,375 - $513,300
72,500 Added 128.55%
128,900 $463,000
Q4 2019

Feb 13, 2020

BUY
$4.96 - $7.75 $279,744 - $437,100
56,400 New
56,400 $411,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $332M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.